SCHEMBL7278095

SCHEMBL7278095

CC(C)[C@H](NC(=O)N(C)Cc1ccccn1)C(=O)NC(Cc1ccccc1)C(O)C(Cc1ccccc1)NC(=O)[C@@H](NC(=O)N(C)Cc1ccccn1)C(C)C

nearest known ligand 0.96

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.96
CYP2D6 P10635 3/20 0.49
CYP1A2 P05177 2/20 0.49
MAPT P10636 2/20 0.49
TSHR P16473 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
CYP3A4 P08684 6/20 0.48
CYP2C19 P33261 2/20 0.48
CTSD P07339 4/20 0.45
MEN1 O00255 1/20 0.44
SLC22A2 O15244 1/20 0.44
SLC22A1 O15245 1/20 0.44
ABCC3 O15438 1/20 0.44
ABCC4 O15439 1/20 0.44
MLNR O43193 1/20 0.44
NR1I2 O75469 1/20 0.44
SLCO2B1 O94956 1/20 0.44
ABCB11 O95342 1/20 0.44
ALDH1A1 P00352 1/20 0.44
PGR P06401 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
A-77003 SCHEMBL6448973 0.98 CA2 (1.00) CA2CYP2D6CYP1A2MAPTTSHR
A-77003 SCHEMBL8749867 0.98 CA2 (1.00) CA2CYP2D6CYP1A2MAPTTSHR
A-77003 SCHEMBL7337518 0.98 CA2 (1.00) CA2CYP2D6CYP1A2MAPTTSHR
A-77003 SCHEMBL2770013 0.98 CA2 (1.00) CA2CYP2D6CYP1A2MAPTTSHR
A-76928 SCHEMBL6449595 0.98 CA2 (1.00) CA2CYP2D6CYP1A2MAPTTSHR
SCHEMBL7341491 0.93 CA2 (0.89) CA2CYP2D6CYP1A2MAPTTSHR
SCHEMBL7305421 0.93 CA2 (0.89) CA2CYP2D6CYP1A2MAPTTSHR
SCHEMBL7331008 0.93 CA2 (0.89) CA2CYP2D6CYP1A2MAPTTSHR
SCHEMBL7332039 0.91 CA2 (0.87) CA2CYP2D6CYP1A2MAPTTSHR
SCHEMBL7330908 0.91 CA2 (0.86) CA2CYP2D6CYP1A2MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0402646-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 1998-07-22 EP disclosed
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 EP disclosed